These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31032642)

  • 1. Assessing upper limb function with ALSFRS-R in amyotrophic lateral sclerosis patients.
    Pinto S; Gromicho M; de Carvalho M
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Aug; 20(5-6):445-448. PubMed ID: 31032642
    [No Abstract]   [Full Text] [Related]  

  • 2. Health Status Perspectives in Amyotrophic Lateral Sclerosis.
    Pinto S; de Carvalho M
    Neurodegener Dis; 2017; 17(6):323-329. PubMed ID: 29084402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis.
    Rooney J; Burke T; Vajda A; Heverin M; Hardiman O
    J Neurol Neurosurg Psychiatry; 2017 May; 88(5):381-385. PubMed ID: 27888187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring the validation of assessing the non-dominant-hand function by ALSFRS-r in Chinese ALS patients.
    Hu F; Jin J; Jia R; Xiang L; Qi H; Zhao X; Dang J
    J Clin Neurosci; 2017 Dec; 46():17-20. PubMed ID: 28887079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of slow and forced vital capacities on ability to predict survival in ALS.
    Pinto S; de Carvalho M
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):528-533. PubMed ID: 28741375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysphagia in Amyotrophic Lateral Sclerosis: Relationships between disease progression and Fiberoptic Endoscopic Evaluation of Swallowing.
    Fattori B; Siciliano G; Mancini V; Bastiani L; Bongioanni P; Caldarazzo Ienco E; Barillari MR; Romeo SO; Nacci A
    Auris Nasus Larynx; 2017 Jun; 44(3):306-312. PubMed ID: 27569290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The R of ALSFRS-R: does it really mirror functional respiratory involvement in amyotrophic lateral sclerosis?
    Pinto S; de Carvalho M
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):120-3. PubMed ID: 25205208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS).
    Fournier CN; Bedlack R; Quinn C; Russell J; Beckwith D; Kaminski KH; Tyor W; Hertzberg V; James V; Polak M; Glass JD
    JAMA Neurol; 2020 Apr; 77(4):480-488. PubMed ID: 31886839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self-report scale (Center for Neurologic Study Bulbar Function Scale).
    Smith RA; Macklin EA; Myers KJ; Pattee GL; Goslin KL; Meekins GD; Green JR; Shefner JM; Pioro EP
    Eur J Neurol; 2018 Jul; 25(7):907-e66. PubMed ID: 29577526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients.
    Park Y; Park J; Kim Y; Baek H; Kim SH
    Nutrition; 2015; 31(11-12):1362-7. PubMed ID: 26429656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study.
    de Sire A; Invernizzi M; Ferrillo M; Gimigliano F; Baricich A; Cisari C; De Marchi F; Foglio Bonda PL; Mazzini L; Migliario M
    NeuroRehabilitation; 2021; 48(1):49-57. PubMed ID: 33386822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical correlates of functional decline in amyotrophic lateral sclerosis.
    Cheong I; Deelchand DK; Eberly LE; Marjańska M; Manousakis G; Guliani G; Walk D; Öz G
    J Neurol Neurosurg Psychiatry; 2019 Mar; 90(3):294-301. PubMed ID: 30467209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the characteristics of patients with amyotrophic lateral sclerosis with neuromuscular junction dysfunction prior to motor neuron degeneration].
    Zhang JH; Chen ZH; Ling L; Cheng HM; Zhang Y; Zhao JR; Huang XS
    Zhonghua Nei Ke Za Zhi; 2024 Jul; 63(7):660-665. PubMed ID: 38951089
    [No Abstract]   [Full Text] [Related]  

  • 14. Longitudinal evaluation of upper extremity reachable workspace in ALS by Kinect sensor.
    de Bie E; Oskarsson B; Joyce NC; Nicorici A; Kurillo G; Han JJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):17-23. PubMed ID: 27813421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of patients with amyotrophic lateral sclerosis attending in a multidisciplinary care unit.
    Rodríguez de Rivera FJ; Oreja Guevara C; Sanz Gallego I; San José Valiente B; Santiago Recuerda A; Gómez Mendieta MA; Arpa J; Díez Tejedor E
    Neurologia; 2011 Oct; 26(8):455-60. PubMed ID: 21419529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
    Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective investigation of the relationship between baseline covariates and rate of ALSFRS-R decline in ALS clinical trials.
    Daghlas I; Lever TE; Leary E
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):206-211. PubMed ID: 29260911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The frequency of ALSFRS-R reversals and plateaus in patients with limb-onset amyotrophic lateral sclerosis: a cohort study.
    Hu N; Shen D; Yang X; Cui L; Liu M
    Acta Neurol Belg; 2022 Dec; 122(6):1567-1573. PubMed ID: 35034333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different patterns of spreading direction and motor neurons involvement in a cohort of limb-onset amyotrophic lateral sclerosis patients from Southern Italy: Potential implication on disease course or progression?
    Milella G; Zoccolella S; Urso D; Nigro S; Tamburrino L; Gnoni V; Filardi M; Logroscino G
    Brain Behav; 2023 Jun; 13(6):e2899. PubMed ID: 37208847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of disease progression rate and related factors in amyotrophic lateral sclerosis patients at initial visit].
    Zhang JH; Wang HF; Yang F; He ZQ; Feng F; Li M; Bai JM; Wang HR; Huang XS
    Zhonghua Yi Xue Za Zhi; 2022 Jan; 102(3):222-227. PubMed ID: 35042292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.